Intellia Therapeutics, Inc.Intellia Therapeutics, Inc.Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc.

No trades
No trades

Fundamentals and stats

EPS and revenue snapshot

In the last quarter, the company reported −0.80 USD per share, beating the −0.80 USD estimate by −0.09%. Revenue for the same period reached ‪7.66 M‬ USD, despite the estimate of ‪12.98 M‬ USD. For the next quarter, analysts expect −0.80 USD in earnings per share and ‪10.23 M‬ USD in revenue.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
Reported
Estimate
Metrics
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Metrics
Reported
Estimate
Surprise